Floatz logo

Octreotide Pamoate

Bariatric Surgery (Gastric Bypass)

Hvidovre University HospitalPhase 4 / ApprovedDormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Bariatric Surgery (Gastric Bypass) cohort.

Asset / SponsorPhaseRating
Orlistat
Kirstine Nyvold Bojsen-Moeller
D

Same molecule, other indications

Octreotide Pamoate is also rated in:

diarrheal diseaseDormant
BB
Indicative ·
71 / 100
View asset →
cirrhosis of liverDormant
BB
Indicative ·
71 / 100
View asset →
esophageal varicesDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →